文献速递临床试验与 GCP流行病学与生物统计

贝叶斯有序格点设计用于I期临床试验

Bayesian Ordered Lattice Design for Phase I Clinical Trials.
PubMed 文献 · Stat Med · 2026-01-01

研究提出贝叶斯有序格点设计(BOLD),用于早期I期临床试验,利用剂量限制性毒性(DLT)率的先验信息和后验更新指导剂量选择、毒性监测、早期终止和最大耐受剂量(MTD)识别,并利用剂量水平间毒性概率的自然顺序关系。该设计计算简单、无需模拟,在确定MTD的准确性上常优于流行方法。

要点

  • BOLD利用先验信息和后验更新指导剂量选择与MTD识别。
  • 利用剂量间毒性概率的自然顺序关系,借鉴其他剂量数据。
  • 计算简单、无需模拟,MTD确定准确性常优于流行方法。

核心结论

  • BOLD框架适用于小样本I期试验,可整合先验信息并利用剂量顺序关系,常提升MTD确定准确性。

研究设计与样本

  • 提出贝叶斯有序格点设计(BOLD),针对早期I期临床试验,采用剂量水平贝叶斯设定和后验概率决策。

主要发现

  • BOLD在确定MTD的准确性上常优于流行方法。
  • BOLD计算简单且避免模拟。

关键数值与推荐

  • 基于DLT率后验概率进行剂量选择、毒性监测、早期终止和MTD识别。

临床怎么用

  • 可用于小样本I期试验,利用先验信息和剂量顺序关系指导剂量递增与MTD确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We develop a new framework specifically for early Phase I clinical trials called Bayesian Ordered Lattice Design (BOLD). This study is motivated by two key factors. First, Phase I clinical trials typically involve relatively small sample sizes, which can make the use of prior information on dose-limiting toxicity (DLT) rates highly significant. To address this challenge, the proposed Bayesian methodology incorporates prior information and posterior updating to guide dose selection, toxicity monitoring, early stopping, and identification of the maximum tolerable dose (MTD). Second, a natural ordering among toxicity probabilities across different dose levels can be utilized, with the idea being that analysis of dose-level posterior probabilities can and should acquire insights from data obtained at other dose levels, by leveraging their order relationship. Our proposed approach employs straightforward dose-level Bayesian specifications and relies on intuitive and clinically interpretable DLT rate posterior probabilities for decision-making. Importantly, we show that it can often outperform popular methods in terms of accuracy in determining the MTD. This Bayesian approach is also computationally simple and avoids simulation.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Wang GM, Tatsuoka C. Bayesian Ordered Lattice Design for Phase I Clinical Trials. Stat Med. 2026. PMID: 41781808. doi:10.1002/sim.70456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。